Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LEVOBUPIVACAINE: 395 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
395
Total FAERS Reports
12 (3.0%)
Deaths Reported
150
Hospitalizations
395
As Primary/Secondary Suspect
82
Life-Threatening
26
Disabilities
Aug 5, 1999
FDA Approved
Discontinued
Status

FDA Application: 020997 ·

First Report: 201005 · Latest Report: 20250615

What Are the Most Common LEVOBUPIVACAINE Side Effects?

#1 Most Reported
Hypotension
38 reports (9.6%)
#2 Most Reported
Anaphylactic reaction
32 reports (8.1%)
#3 Most Reported
Cardiac arrest
26 reports (6.6%)

All LEVOBUPIVACAINE Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Hypotension 38 9.6% 1 17
Anaphylactic reaction 32 8.1% 0 9
Cardiac arrest 26 6.6% 6 11
Foetal exposure during pregnancy 24 6.1% 0 3
Maternal exposure during pregnancy 21 5.3% 0 12
Drug ineffective 20 5.1% 0 11
Premature baby 20 5.1% 0 0
Bradycardia 19 4.8% 0 5
Exposure during pregnancy 19 4.8% 1 7
Acute generalised exanthematous pustulosis 18 4.6% 0 7
Nausea 18 4.6% 0 14
Horner's syndrome 17 4.3% 0 6
Erythema 15 3.8% 0 12
Low birth weight baby 14 3.5% 0 0
Mydriasis 14 3.5% 0 13
Rash 14 3.5% 0 6
Loss of consciousness 13 3.3% 0 8
Maternal exposure during delivery 13 3.3% 0 7
Muscular weakness 13 3.3% 0 7
Seizure 13 3.3% 0 5

Who Reports LEVOBUPIVACAINE Side Effects? Age & Gender Data

Gender: 71.7% female, 28.3% male. Average age: 52.5 years. Most reports from: GB. View detailed demographics →

Is LEVOBUPIVACAINE Getting Safer? Reports by Year

YearReportsDeathsHosp.
2010 1 0 0
2011 2 0 1
2012 1 0 0
2013 5 0 2
2014 12 0 6
2015 19 2 3
2016 20 2 4
2017 19 1 15
2018 26 0 14
2019 10 0 6
2020 23 0 13
2021 20 2 6
2022 3 0 0
2023 23 2 2
2024 3 0 3
2025 5 0 3

View full timeline →

What Is LEVOBUPIVACAINE Used For?

IndicationReports
Product used for unknown indication 61
Epidural anaesthesia 44
Anaesthesia 38
Nerve block 35
Local anaesthesia 27
Analgesic therapy 26
Epidural analgesia 24
Postoperative analgesia 23
Foetal exposure during pregnancy 12
General anaesthesia 11

LEVOBUPIVACAINE vs Alternatives: Which Is Safer?

LEVOBUPIVACAINE vs LEVOCARNITINE LEVOBUPIVACAINE vs LEVOCETIRIZINE LEVOBUPIVACAINE vs LEVODOPA LEVOBUPIVACAINE vs LEVOFLOXACIN LEVOBUPIVACAINE vs LEVOKETOCONAZOLE LEVOBUPIVACAINE vs LEVOLEUCOVORIN LEVOBUPIVACAINE vs LEVOMEPROMAZINE LEVOBUPIVACAINE vs LEVOMETHADONE LEVOBUPIVACAINE vs LEVOMILNACIPRAN LEVOBUPIVACAINE vs LEVONORGESTREL

Official FDA Label for LEVOBUPIVACAINE

Official prescribing information from the FDA-approved drug label.